Table 2:
miRNA | Targets | Process | References |
---|---|---|---|
TLR pathway | |||
miR-9 | NF-κB1/p50 | Transcription by NF-κB is decreased | [123] |
miR-16 | TNF-α | Decrease levels of inflammatory | [124] |
miR-17–5p, 20a, 106a | Transcription factor CBF | Inhibition of monocyte maturation | [125] |
miR-21 | PDCD4, IL12p35 | Derepression of IL-10 | [126] |
miR-27b | PPARγ | [127] | |
miR-105 | TLR2 | [128] | |
miR-106 | IL-10 | Cooperates with RNA binding protein | [129] |
miR-125b | TNF-α | to decrease IL-10 | [130] |
miR-145 | MAL | Impedes TLR signaling | [131] |
miR-146a | TRAF6, IRAK1, IRAK2 | Negative feedback regulator in TLR signaling | [132] |
miR-155 | AID, MyD88, TAB2, IKKԑ, SHIP1, SOCS1, C/.EBPBβ | Proinflammatory in TLR signaling | [133] |
miR-199 | IKKβ | TLR4/NF-κB p65/NGAL pathways | [134] |
miR-221 | TNF-α | [135] | |
miR-223 | TLR3, TLR4, IKKα | Granulopoiesis and monocyte activation | [136] |
Let-7i and let7e | TLR4 | Downregulate inflammatory signaling | [137] |
T cell development and function | |||
miR-181a | SHP2 | T cells: strength of the transduced T-cell receptor signal. | [138] |
miR-155 | SOCS1 | miR-155-deficient mice suffer impaired survival of Treg, T regs/Th17 ratio | [139] |
miR-146a | STAT1 | miR-146a-deficient Treg (FoxP3) cannot inhibit hyperactive immune system. Upregulated in RA | [140] |
miR-17~92 cluster | pten | immunoproliferative disorder and autoimmune disease | [141] |
miR-326 | Ets-1 transcription factor | autoimmune inflammation | [142] |
B cells development and function | |||
miR-181a | Lin28/Mcl-1 | guided B-cell development | [143] |
miR-150 | c-Myb and Foxp1 | B-cell development | [144] |
miR-34a | c-Myb and Foxp1 | B cell development | [145] |
miR-155 | Pu.1, SHIP1 and AID | regulate antibody secretion and class-switch recombination | [146] |
miR-181b | reduce the class-switch recombination rates | [147] |